Mini Review
Accepted on 31 Jan 2025
Bisphenol A and DDT disrupt adipocyte function in the mammary gland: Implications for breast cancer risk and progression
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1490898
Type at least 3 characters
29,909 articles
Articles
Case Report
Published on 31 Jan 2025
Oncocytic papillary renal cell carcinoma (OPRCC): 2 case report and literature review
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1541692
- 161 views
Original Research
Published on 31 Jan 2025
A nomogram for predicting prognosis for young cervical neuroendocrine carcinoma: A SEER-based study and external validation
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1463422
- 125 views
Original Research
Published on 31 Jan 2025
Antiangiogenic therapy with recombinant human endostatin may improve blood perfusion of cervical node with necrosis in nasopharyngeal carcinoma patients: a preliminary study by using contrast-enhanced ultrasound
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1521762
- 172 views
Perspective
Published on 31 Jan 2025
Inclusive mentorship of pediatric trainees: pediatric oncology as a microcosm
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1531784
- 225 views
Systematic Review
Published on 31 Jan 2025
Prognostic and clinicopathological role of soluble programmed cell death ligand-1 in patients with diffuse large B-cell lymphoma: a meta-analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1506799
- 101 views
Mini Review
Published on 31 Jan 2025
Intracranial germ cell tumors: advancement in genomic diagnostics and the need for novel therapeutics
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1513258
- 106 views
Original Research
Published on 31 Jan 2025
Study on the value of gastrin 17 and aldehyde dehydrogenase 1 in gastric juice for early diagnosis in gastric cancer
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2025.1521868
- 173 views
Original Research
Published on 31 Jan 2025
Prognosis of nodal micrometastasis in resectable pN0 non-small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1424682
- 187 views
Original Research
Published on 31 Jan 2025
Risk factors for pelvic lymph node metastasis in cervical cancer: a retrospective analysis of 186 patients
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1525946
- 158 views
Original Research
Published on 31 Jan 2025
Adeno-associated virus mediated artificial circular RNA for triggering cancer immunotherapy to treat prostate cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1443571
- 109 views
Systematic Review
Published on 31 Jan 2025
Risk factors for lateral pelvic lymph node metastasis in patients with rectal neuroendocrine tumors: a systematic review and meta-analysis
in Gastrointestinal Cancers: Colorectal Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1500623
- 134 views
Correction
Published on 31 Jan 2025
Corrigendum: First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP: TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1544394
- 106 views
Correction
Published on 31 Jan 2025
Corrigendum: Research progress of breast cancer surgery during 2010–2024: a bibliometric analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1550434
Review
Accepted on 30 Jan 2025
Updated review on novel therapies and ongoing clinical trials for high-risk non-muscle invasive bladder cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1519428
Correction
Accepted on 30 Jan 2025
Corrigendum: Predicting epidermal growth factor receptor mutation status of lung adenocarcinoma based on PET/CT images using deep learning
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1564325